Clinical Trials on BRAF V600E-mutant Metastatic Colorectal Cancer in Canada
Total 91 results
-
PfizerMerck KGaA, Darmstadt, Germany; Ono Pharmaceutical Co. Ltd; Pierre Fabre MedicamentCompletedBRAF V600E-mutant Metastatic Colorectal CancerUnited States, Spain, Korea, Republic of, United Kingdom, Australia, Czechia, Taiwan, Belgium, France, Hungary, Canada, Japan, Russian Federation, Netherlands, Israel, Germany, Turkey, Austria, Brazil, Poland, Italy, Argentina, Chile, Denmar... and more
-
Novartis PharmaceuticalsActive, not recruitingBRAF V600 Colorectal CancerBelgium, Germany, Netherlands, Spain, Singapore, Australia, United Kingdom, Israel, Canada, United States
-
Array BioPharmaTerminatedLocally Advanced Metastatic BRAF Mutant MelanomaAustralia, Canada, Netherlands, United States
-
University Health Network, TorontoCompletedColorectal Cancer | KRAS Wildtype | NRAS Wildtype | BRAF WildtypeCanada
-
Institut Investigacio Sanitaria Pere VirgiliInstitut Català d'Oncologia; Hospital Universitario Ramon y Cajal; Hospital Arnau... and other collaboratorsRecruitingMetastatic Colorectal Cancer | Metastatic Lung Cancer | Metastatic Breast Cancer | Metastasis | Metastatic Prostate CancerSpain
-
Alethia BiotherapeuticsRecruitingMetastatic Colorectal CancerCanada
-
University Health Network, TorontoRecruitingColorectal Cancer | Lung Metastases | Colorectal Cancer MetastaticCanada
-
Ottawa Hospital Research InstituteSanofi; Hoffmann-La RocheWithdrawn
-
University Health Network, TorontoBritish Columbia Cancer Agency; Terry Fox Research InstituteActive, not recruitingColorectal Cancer | Colorectal Cancer Metastatic | Hepatic MetastasesCanada
-
University Health Network, TorontoRecruitingMetastatic Colorectal CancerCanada
-
Ottawa Hospital Research InstituteSanofi; Pfizer; Hoffmann-La Roche; Ottawa Regional Cancer FoundationTerminatedMetastatic Colorectal CancerCanada
-
Ottawa Hospital Research InstituteBayerCompletedMetastatic Colorectal CancerCanada
-
AHS Cancer Control AlbertaCross Cancer InstituteCompletedMetastatic Colorectal CancerCanada
-
British Columbia Cancer AgencyBayerCompleted
-
PeriPharmPersonalized Medicine Partnership for CancerCompletedColorectal Cancer MetastaticCanada
-
CR-CSSS Champlain-Charles-Le MoyneSanofi; Regeneron Pharmaceuticals; Quebec Clinical Research Organization in CancerTerminatedMetastatic Colorectal CancerCanada
-
PeriPharmPersonalized Medicine Partnership for CancerCompletedColorectal Cancer MetastaticCanada
-
British Columbia Cancer AgencyCompleted
-
Centre hospitalier de l'Université de Montréal...Exactis Innovation; Chaire Roger Des Groseillers d'oncologie chirurgicale HBP... and other collaboratorsRecruitingColorectal Cancer MetastaticCanada
-
Canadian Cancer Trials GroupPfizerCompletedMetastatic Colorectal CancerCanada
-
Day One Biopharmaceuticals, Inc.RecruitingMelanoma | Colorectal Cancer | Solid Tumor | Non Small Cell Lung Cancer | Bladder Cancer | Thyroid Cancer, Papillary | Pilocytic Astrocytoma | Bladder Urothelial Carcinoma | Non-Small Cell Adenocarcinoma | MEK Mutation | RAS Mutation | Pancreatic Acinar Carcinoma | RAF Mutation | CRAF Gene Amplification | RAF1 Gene Amplification and other conditionsUnited States, Canada, Korea, Republic of, Spain, Australia, Belgium, France
-
Gerald BatistBayer; Quebec Clinical Research Organization in CancerUnknownMetastatic Colorectal CancerCanada
-
Novartis PharmaceuticalsActive, not recruitingMelanoma | Pancreatic Cancer | Triple Negative Breast Cancer | Head and Neck Squamous Cell Cancer | Esophageal Squamous Cell Cancer | BRAF Mutant Colorectal Cancer | Cervical Squamous Cell Cancer | Lung Squamous Cell CancerCanada, Italy, Spain, Germany, Netherlands, United States, France
-
AmgenCompletedMetastatic Colorectal CancerCanada, United States
-
AHS Cancer Control AlbertaNot yet recruitingColorectal Cancer | Liver Metastasis Colon CancerCanada
-
Hamilton Health Sciences CorporationCompletedSurgery | Liver Metastases | Complication | ColoRectal Cancer | Liver Metastasis Colon CancerCanada
-
PfizerCompletedMetastatic Colorectal CancerBelgium, Canada, France, Spain, United States, Italy, Netherlands
-
Cadex GenomicsCompletedMetastatic Colorectal Cancer | Metastatic Breast Cancer | Metastatic Non-Small Cell Lung CarcinomaUnited States, Canada
-
University of WashingtonNational Cancer Institute (NCI)CompletedColorectal Cancer | Metastatic CancerUnited States, Canada
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingColorectal Adenocarcinoma | Stage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Colorectal Carcinoma Metastatic in the LungUnited States, Canada
-
Merck Sharp & Dohme LLCArray BioPharmaCompletedMetastatic Colorectal CancerUnited States, Canada
-
Novartis PharmaceuticalsCompletedMetastatic Colorectal CancerSpain, Italy, Singapore, Canada, Israel, Korea, Republic of, Netherlands, Australia
-
Eli Lilly and CompanyCompletedMetastatic Colorectal CancerSpain, United States, Canada
-
Array BioPharmaCompletedMetastatic Colorectal CancerUnited States, Australia, Belgium, Canada, France, Israel, Italy, Netherlands, Singapore, Spain
-
MedImmune LLCTerminatedMetastatic Microsatellite-stable Colorectal CancerUnited States, Spain, France, Australia, Canada
-
Bristol-Myers SquibbTerminatedHead and Neck Cancer | Neoplasm Metastasis | Colorectal CancerUnited States, Canada
-
Grupo Espanol Multidisciplinario del Cancer DigestivoAmgen; TFS Trial Form SupportCompletedMetastatic Colorectal CancerSpain
-
Boston Scientific CorporationBiocompatibles UK LtdCompletedColorectal Cancer MetastaticKorea, Republic of, Canada, United States, Belgium, Spain, United Kingdom, France, Germany, Austria, Singapore, China, Italy, Poland
-
Gilead SciencesActive, not recruitingMetastatic Colorectal CancerUnited States, Spain, Australia, Hong Kong, France, Belgium, Canada, Puerto Rico, Germany, Italy
-
Hoffmann-La RocheRecruitingMetastatic Colorectal CancerUnited States, Korea, Republic of, United Kingdom, Australia, Germany, Taiwan, Spain, Canada, Italy, Poland, Denmark, France
-
AmgenCompletedMetastatic Colorectal CancerRomania, Canada, Korea, Republic of, Philippines, Lithuania, Serbia, Latvia, Estonia, Greece, India, China, Croatia, Mexico, Malaysia, Chile, Brazil
-
Janssen Research & Development, LLCRecruitingAdvanced or Metastatic Colorectal CancerUnited States, Korea, Republic of, Taiwan, Malaysia, Germany, Italy, Spain, Belgium, Canada, Puerto Rico, China
-
University Health Network, TorontoSunnybrook Health Sciences CentreCompleted
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedMetastatic Colorectal CancerTurkey, Poland, Brazil, France, Ireland, Italy, Portugal, Romania, Ukraine, Bulgaria, Australia, Belgium, Croatia, Panama, Slovakia, Slovenia
-
PfizerEli Lilly and Company; Merck Sharp & Dohme LLC; Merck KGaA, Darmstadt, GermanyRecruitingMetastatic Colorectal CancerUnited States, Denmark, Spain, Australia, France, Italy, Belgium, Slovakia, Canada, Czechia, Germany, Netherlands, Norway, Poland, Sweden, United Kingdom
-
PfizerCompletedMetastatic Colorectal CancerBelgium, Bulgaria, Hungary, Spain, Ukraine, Germany, Ireland, Korea, Republic of, Poland, Portugal, Russian Federation, Slovakia, Sweden, Mexico, Serbia, Singapore, Taiwan, Thailand, United Kingdom, Cyprus, Czech Republic, India, Ar... and more
-
Novartis PharmaceuticalsActive, not recruitingMetastatic Colorectal CancerCanada, Taiwan, Belgium, Germany, Spain, Italy, Czechia, Switzerland, Australia, United States, Japan, Singapore, United Kingdom, France, Israel, Hong Kong, Korea, Republic of
-
University Health Network, TorontoPrincess Margaret Hospital, Canada; Ontario Institute for Cancer ResearchCompletedBreast Cancer | Colorectal Cancer | Metastatic | Gynecological Cancer | Melanoma Cancer | Eligible for Phase I or Phase II StudyCanada
-
Merck Sharp & Dohme LLCCompletedMetastatic Colorectal CancerCanada, Hungary, United States, Australia, Belgium, Chile, Colombia, France, Germany, Japan, Korea, Republic of, Latvia, Lithuania, Russian Federation, South Africa, Spain, Turkey, Ukraine
-
Mirati Therapeutics Inc.Active, not recruitingMetastatic Colorectal Cancer | Advanced Colorectal CancerUnited States, Denmark, Finland, Italy, Spain, Belgium, Romania, Taiwan, Thailand, France, Germany, Korea, Republic of, China, Malaysia, Hong Kong, Australia, Austria, Puerto Rico, Singapore, Canada, Portugal, Poland, Greece, United Kingdom and more